A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity AT Huang, B Garcia-Carreras, MDT Hitchings, B Yang, LC Katzelnick, ... Nature communications 11 (1), 4704, 2020 | 1087* | 2020 |
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study OT Ranzani, MDT Hitchings, M Dorion, TL D’Agostini, RC de Paula, ... bmj 374, 2021 | 362 | 2021 |
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study MDT Hitchings, OT Ranzani, MSS Torres, SB de Oliveira, M Almiron, ... The Lancet Regional Health-Americas 1, 100025, 2021 | 213* | 2021 |
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26. COV2. S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study T Cerqueira-Silva, JR Andrews, VS Boaventura, OT Ranzani, ... The Lancet Infectious Diseases 22 (6), 791-801, 2022 | 122 | 2022 |
Quantifying airborne dispersal routes of pathogens over continents to safeguard global wheat supply M Meyer, JA Cox, MDT Hitchings, L Burgin, MC Hort, DP Hodson, ... Nature Plants 3 (10), 780-786, 2017 | 95 | 2017 |
Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo MDT Hitchings, OT Ranzani, M Dorion, TL D’Agostini, RC de Paula, ... Nature communications 12 (1), 6220, 2021 | 89* | 2021 |
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil OT Ranzani, MDT Hitchings, RL de Melo, GVA de França, ... Nature communications 13 (1), 5536, 2022 | 80 | 2022 |
Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States B Yang, AT Huang, B Garcia-Carreras, WE Hart, A Staid, MDT Hitchings, ... Nature communications 12 (1), 3560, 2021 | 51 | 2021 |
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials NE Dean, AP y Piontti, ZJ Madewell, DAT Cummings, MDT Hitchings, ... Vaccine 38 (46), 7213-7216, 2020 | 39 | 2020 |
Linear growth faltering and the role of weight attainment: Prospective analysis of young children recovering from severe wasting in Niger S Isanaka, MDT Hitchings, F Berthé, A Briend, RF Grais Maternal & child nutrition 15 (4), e12817, 2019 | 31 | 2019 |
Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: A 3-arm, open-label, cluster-randomized trial ME Coldiron, B Assao, AL Page, MDT Hitchings, G Alcoba, I Ciglenecki, ... PLoS medicine 15 (6), e1002593, 2018 | 29 | 2018 |
Use of recently vaccinated individuals to detect bias in test-negative case–control studies of COVID-19 vaccine effectiveness MDT Hitchings, JA Lewnard, NE Dean, AI Ko, OT Ranzani, JR Andrews, ... Epidemiology 33 (4), 450-456, 2022 | 27 | 2022 |
Risk factors for healthcare personnel infection with endemic coronaviruses (HKU1, OC43, NL63, 229E): results from the respiratory protection effectiveness clinical trial (ResPECT) DAT Cummings, LJ Radonovich Jr, GJ Gorse, CA Gaydos, MT Bessesen, ... Clinical Infectious Diseases 73 (11), e4428-e4432, 2021 | 24 | 2021 |
Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA. 1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative … ML Lind, AJ Robertson, J Silva, F Warner, AC Coppi, N Price, C Duckwall, ... PLoS medicine 19 (12), e1004136, 2022 | 23* | 2022 |
Using simulation to aid trial design: Ring-vaccination trials MDT Hitchings, RF Grais, M Lipsitch PLoS neglected tropical diseases 11 (3), e0005470, 2017 | 23 | 2017 |
Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: a cross-sectional survey MO Fofana, N Nery Jr, JP Aguilar Ticona, EMM de Andrade Belitardo, ... PLoS Medicine 19 (9), e1004093, 2022 | 20* | 2022 |
Analyzing vaccine trials in epidemics with mild and asymptomatic infection R Kahn, M Hitchings, R Wang, SE Bellan, M Lipsitch American journal of epidemiology 188 (2), 467-474, 2019 | 20 | 2019 |
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013–2016 West Africa Ebola outbreak in Guinea Y Boum, A Juan-Giner, M Hitchings, A Soumah, T Strecker, M Sadjo, ... Vaccine 38 (31), 4877-4884, 2020 | 19 | 2020 |
Competing effects of indirect protection and clustering on the power of cluster-randomized controlled vaccine trials MDT Hitchings, M Lipsitch, R Wang, SE Bellan American journal of epidemiology 187 (8), 1763-1771, 2018 | 19 | 2018 |
Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population ML Lind, M Dorion, AJ Houde, M Lansing, S Lapidus, R Thomas, I Yildirim, ... Nature communications 14 (1), 5055, 2023 | 16 | 2023 |